UniXell Company
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
Employee Number:
11-50
Headquarters:
Shanghai,Shanghai,China,Asia
Founded Date:
2021-01-01
Industry:
NeuroTech
Sub-Industry:
Neuro Medicine (Tech and Pharma)
Investors:
CDH Investments, Sherpa Healthcare Partners, Fosun Pharma, GL Ventures LLC, TF Capital
Ipo Status:
private
City:
Shanghai
Region:
Shanghai
Country:
China